InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by DENKHAUS DONALD A, Director. Officer active across 1 companies, notably Catalyst Pharmaceuticals, INC.. Aggregated, 6 disclosures have been recorded. The latest transaction was disclosed on 10 January 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
€89,13240,000 shares@ €2.22830.0023% mcap37.5% of flow
Common stock, par value $0.001 per share
SEC:0001161697-22-000045·
€89,13240,000 shares@ €2.22830.0023% mcap18.8% of flow
Common stock, par value $0.001 per share
SEC:0001161697-22-000045:0·
€148,44550,000 shares@ €2.96890.0039% mcap62.5% of flow
Common stock, par value $0.001 per share
SEC:0001161697-22-000031·
€148,44550,000 shares@ €2.96890.0039% mcap31.2% of flow
Common stock, par value $0.001 per share
SEC:0001161697-22-000031:0·
1,333 shares
Common Stock, par value $0.001 per share
SEC:0001161697-21-000553·
1,333 shares
Common Stock, par value $0.001 per share
SEC:0001161697-21-000553:0·
6 of 6 declarations
About DENKHAUS DONALD A
Donald A. Denkhaus is a Board Member at Catalyst Pharmaceuticals, Inc. He plays a key role in the governance of the company, participating in strategic decisions and ensuring compliance with regulations. His expertise in the pharmaceutical sector is an asset to the board.
